Saba Capital Management acquires $162,998 Ellsworth Growth & Income Fund Investing.com · News 25m ago
Capricor shares plunge 80% as FDA cites trial violations in drug rejection Investing.com · Investing_news 41m ago
Capricor shares plunge 80% as FDA cites trial violations in drug rejection Investing.com · News 41m ago